News
Altisource (ASPS) Q2 2025 Earnings Call Transcript
Net Income Attributable to Altisource: Net income attributable to Altisource (GAAP) was $16.6 million for Q2 2025, compared to an $8.3 million GAAP net loss in Q2 2024; This includes an income tax benefit from the reversal of India-related tax reserves.
Tesla (TSLA) Q2 2025 earnings results and conference call transcript
Tesla is out with its Q2 2025 earnings results, and the stock is moving in after-hours trading. The EV maker reported earnings-per-share of $0.27/share and revenues of $19.335 billion, missing analysts' EPS expectation of $0.39/share and estimated revenue of $21.11 billion.
Universal Insurance Holdings, Inc. (UVE) Q2 2025 Earnings Call Transcript
Universal Insurance Holdings, Inc. ( NYSE: UVE) Q2 2025 Earnings Conference Call July 25, 2025 10:00 AM ET Arash Soleimani - Chief Strategy Officer Frank Crawford Wilcox - Chief Financial Officer Stephen Joseph Donaghy - CEO & Director
Flagstar Financial (NYSE:FLG) lowered its guidance for 2025 net interest income and earnings, as the company continues to ...
Asset quality improved in Q2 2025, but a large commercial real estate charge-off drove a rise in net charge-offs for the quarter. These 10 stocks could mint the next wave of millionaires › Tompkins ...
Tesla’s battery business has been feeling the pain, too. For a while, this was a growth area for the company, albeit one with ...
Solid-state battery developer QuantumScape has posted its quarterly fiscal report and letter to shareholders for Q2 2025.
Key Points - Adjusted earnings per share (EPS) of $3.49 in Q2 2025 beat analyst estimates by 2.65%, while GAAP revenue in Q2 2025 was just shy of expectations. Free cash flow (non-GAAP) rose 59% to ...
ET with analyst reactions Shares of Tesla (NASDAQ:TSLA) are straddling the flatline in postmarket trading as the company’s ...
IBM has released its Q2 2025 results, which showed the company beating analyst expectations. Despite outperforming EPS and ...
Second-quarter earnings come amid many high-level challenges for the biopharma industry. How will these five closely watched ...
Fidelity Investments reports a 2.74% Q1 loss for its Balanced Fund. See how equity picks and bond strategy shaped results.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback